Navigation Links
Dehaier Medical Receives Software Copyrights for Four Proprietary Technologies
Date:7/12/2012

BEIJING, July 12, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has obtained software copyrights from the National Copyright Administration of PRC for four of its proprietary technologies, including:

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO )

  • Analysis and Monitoring Software of Adsorption Tower Oxygen Generation Process;
  • Dehaier Homecare CPAP Controlling Software;
  • Ventilator of CPAP Controlling Software; and
  • Air Compressor Controlling Software.

These copyrights have been approved for 50 years.  In addition to providing the Company protection in the event of infringement, the software copyright registration is essential to the Company's identification as a "software enterprise" or a "high-technology enterprise." These statuses are important to Dehaier, as they allow the Company to receive preferential government treatment, such as subsidies and tax benefits. 

Mr. Ping Chen, CEO of Dehaier, commented, "We continue to focus on developing quality homecare medical devices, which rely on precise IT and software applications that Dehaier develops internally.  These copyrights are important in protecting the technology that Dehaier is developing, especially as we introduce more products to market.  We also expect to benefit from the favorable policies and subsidies from China's government as a result of our treatment as a hi-tech enterprise.  With the addition of these copyrights, we have two utility model patents, four design patents and nine software copyrights.  We will continue to protect our intellectual property portfolio in unison with strengthening our R&D capabilities, increasing our brand recognition, and gaining market share."

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the future validity of its copyrights or status as a hi-tech enterprise. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Contact Us

Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn

Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn

The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com

In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com


'/>"/>
SOURCE Dehaier Medical Systems Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dehaier Medical Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG
2. Dehaier Medical to Present at the CFA 2012 Cross-Continental Summit on Investment in Shanghai
3. Dehaier Medical Announces 2012 First Quarter Financial Results
4. Dehaier Medical to Report First Quarter 2012 Financial Results on May 9th, 2012
5. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
6. inVentiv Medical Management Forms Partnership with Vital Decisions
7. ACR Chooses NDSC to Deliver ACR Select, a Comprehensive EHR-Enabled Medical Imaging Clinical Decision Support Platform
8. Integrity Life Sciences Receives US FDA 510(k) Clearance for its Integrity Spinal Care System Medical Device
9. Medical Diagnostic & Therapeutic Ultrasound Devices Market (2012 - 2017) - Global Trends & Competitive Analysis
10. Solta Medical to Present at the JMP Securities Healthcare Conference
11. Mindray Medical to Present at AACC Clinical Lab Expo 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 6.83% during the period ... growth prospects of the global travel vaccines market for 2016-2020. To ... the sales of various vaccines administered to actively immunize meningococcal disease, ...
(Date:12/9/2016)... 2016  Axovant Sciences Ltd. (NYSE: ... on the treatment of dementia, today announced a ... 2b trial evaluating treatment with intepirdine (RVT-101), combined ... plus placebo in people with mild-to-moderate Alzheimer,s disease. ... to treatment was associated with reduced progression in ...
(Date:12/8/2016)... , Dec. 8, 2016 IRIDEX Corporation (NASDAQ: ... newly issued shares of common stock, $0.01 par value (the ... underwritten public offering.  The final terms of the Offering will ... pricing, and there can be no assurance as to whether ... expects to use the net proceeds it will receive from ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... ... ... David J. Dykeman , Ginger Pigott , and J. Rick ... West, Dec. 12, 2016, at the Fairmont Newport Beach in California. Greenberg Traurig is ... Sciences & Medical Technology Group have been featured speakers at every DeviceTalks conference since ...
Breaking Medicine News(10 mins):